Transplantation, AutologousHematopoietic Stem Cell TransplantationStem Cell TransplantationPeripheral Blood Stem Cell TransplantationMultiple MyelomaTransplantation, HomologousBone MarrowAntineoplastic Combined Chemotherapy ProtocolsBone Marrow TransplantationMelphalanTransplantation ConditioningCombined Modality TherapyBone Marrow CellsTreatment OutcomeRemission InductionStem CellsSalvage TherapyDisease-Free SurvivalCyclophosphamideEtoposideHodgkin DiseaseLymphoma, Non-HodgkinHematopoietic Stem Cell MobilizationBone Marrow PurgingRecurrenceCytarabineGraft vs Host DiseaseHematopoietic Stem CellsMyeloablative AgonistsCarmustineSurvival RateThiotepaWhole-Body IrradiationHematologic NeoplasmsVincristineSurvival AnalysisBusulfanRetrospective StudiesAntigens, CD34Lymphoma, Mantle-CellGraft SurvivalDoxorubicinAmyloidosisBone and BonesPrognosisGranulocyte Colony-Stimulating FactorDexamethasoneBoronic AcidsPyrazinesFollow-Up StudiesAntineoplastic Agents, AlkylatingTime FactorsLymphoma, FollicularAntibodies, Monoclonal, Murine-DerivedLeukapheresisLymphoma, T-Cell, PeripheralAutograftsIfosfamideAntineoplastic AgentsMesenchymal Stem Cell TransplantationThalidomideLymphomaLiver TransplantationTransplantation ChimeraLeukemia, Myeloid, AcutePrednisoneInduction ChemotherapyNeoplasm, ResidualTissue DonorsPodophyllotoxinLymphoma, Large B-Cell, DiffuseHematopoiesisCell DifferentiationMyelodysplastic SyndromesCell TransplantationMaintenance ChemotherapyCord Blood Stem Cell TransplantationBlood Component RemovalLymphoma, B-CellBone Marrow DiseasesLeukemiaAntibodies, MonoclonalMitoxantroneProspective StudiesBlood Transfusion, AutologousKidney TransplantationEmbryonic Stem CellsLeukemia, MyeloidImmunosuppressive AgentsIdarubicinHistocompatibility TestingCells, CulturedEnteropathy-Associated T-Cell LymphomaLeukemia, Plasma CellNeoplasms, Second PrimaryCarboplatinT-LymphocytesAdult Stem CellsCisplatinHistocompatibility